Tatsis Ourania
- SEC CIK
- 0001789815
In the past year, 7 open-market sale filings worth $6.51M and no purchases.
Current role at each company
- VRTX Vertex Pharmaceuticals IncEVP, Chief Reg. & Quality Off.as of Jul 23, 2026
- ODTX Odyssey Therapeutics, Inc.Directoras of May 11, 2026
- VERV Verve Therapeutics, Inc.Directoras of Jul 28, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.51M
- 7 filings
- Net
- −$6.51M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Tatsis Ourania as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRTX Vertex Pharmaceuticals Inc
EVP, Chief Reg. & Quality Off.30 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 (view filing) | Feb 11 | 3 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −290 | $235.09 | −$68.2K | −0.5%57.7K after | 4 lots |
| Feb 22, 2022 (view filing) | Feb 18 | 4 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −519 | $231.00 | −$119.9K | −1.0%53.1K after | 4 lots |
| Feb 28, 2022 (view filing) | Feb 25 | 3 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −325 | $230.95 | −$75.1K | −0.6%50.2K after | 5 lots |
| Mar 21, 2022 (view filing) | Mar 17 | 4 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −2.83K | $250.11 | −$708.6K | −5.6%47.4K after | 2 lots |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −1.40K | $298.97 | −$418.6K | −2.9%46.1K after | 5 lots |
| Feb 14, 2023 (view filing) | Feb 13 | 1 day | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −275 | $298.99 | −$82.2K | −0.4%65.8K after | 5 lots |
| Feb 16, 2023 (view filing) | Feb 14 | 2 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −320 | $298.52 | −$95.5K | −0.5%65.4K after | 5 lots |
| Feb 22, 2023 (view filing) | Feb 21 | 1 day | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −480 | $293.75 | −$141.0K | −0.8%60.5K after | 4 lots |
| Feb 28, 2023 (view filing) | Feb 27 | 1 day | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −354 | $287.48 | −$101.8K | −0.6%56.8K after | 3 lots |
| Aug 14, 2023 (view filing) | Aug 10 | 4 days | Tatsis OuraniaEVP, Chief Reg. & Quality Off. | SSale | −5.75K | $345.79 | −$1.99M | −10.1%51.1K after | 10b5-1 |